{"id":4119,"date":"2019-06-07T00:29:28","date_gmt":"2019-06-06T14:29:28","guid":{"rendered":"https:\/\/doseme-rx.com\/?p=4119"},"modified":"2021-03-24T14:18:42","modified_gmt":"2021-03-24T04:18:42","slug":"portugals-national-health-service","status":"publish","type":"post","link":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service","title":{"rendered":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service"},"content":{"rendered":"<p><strong>MOORESTOWN, N.J., (June 6, 2019) &#8211; Tabula Rasa HealthCare, Inc<\/strong>. (TRHC) (NASDAQ: TRHC), precision dosing software company DoseMe, today announced a three-year agreement with Portugal\u2019s National Health Service, <a href=\"http:\/\/www.chlo.min-saude.pt\" target=\"_blank\" rel=\"noopener noreferrer\">Centro Hospitalar Lisboa Ocidental<\/a> (CHLO) for DoseMe\u2019s proprietary dose optimization software &#8211; DoseMeRx.<\/p>\n<p>\u201cTherapeutic drug monitoring of medications that have a narrow therapeutic window is a challenging element for any hospital pharmacy team, and our center has a long tradition of it. That\u2019s why we strive for consistent decision support solutions to help us develop clinical excellence,\u201d said F\u00e1tima Falc\u00e3o, PhD, Director of Pharmacy, Centro Hospitalar Lisboa Ocidental.<\/p>\n<p>\u201cDoseMe has provided our team with a consistent, efficient and easy-to-use means of supporting our dosing decisions for these drugs. Additionally, and in accordance with continuous improvement, DoseMeRx has made it possible to incorporate some of our feedback, which we consider very positive. Its friendliness also has allowed us to optimize the process itself, improving dosing individualization and therefore patient outcomes, which is directly aligned with our ultimate goal,\u201d she said.<\/p>\n<p>Established in 2006, CHLO is a health network of three hospitals including, Egas Moniz, Santa Cruz and S\u00e3o Francisco Xavier in Lisbon, Portugal. CHLO has clinical expertise in differentiated healthcare areas, benefiting from the acknowledged quality of care among all of its hospital units. As a medical support service, the Pharmacy Department adopts principles, values and mission policies of the organization, including the commitment to continuous training, teaching and research.<\/p>\n<p>\u201cIt\u2019s a privilege to partner with CHLO to help simplify their workflows in their mission to provide the best individualized care for their patients,\u201d said TRHC\u2019s Chairman and CEO Calvin H. Knowlton, Ph.D. \u201cThis partnership is representative of Portugal\u2019s National Health Service\u2019s commitment to ensure the patient is always the top priority in decision making and ensuring their clinicians have the tools to help them be the best they can be for every patient, every time,\u201d he said.<\/p>\n<p>\u201cWorking with F\u00e1tima and her team, it\u2019s clear they are committed to the delivery of high-quality care and recognize the importance of individualizing medication therapy for every patient,\u201d said Charles Cornish, Chief Executive Officer, DoseMe. \u201cI\u2019m honored to be working with CHLO andproviding the opportunity to create new efficiencies in medication management that will lead to a significant impact on patient safety and outcomes.\u201d<\/p>\n<p><a href=\"http:\/\/www.globenewswire.com\/news-release\/2019\/06\/06\/1865280\/0\/en\/Tabula-Rasa-HealthCare-s-DoseMe-Signs-3-Year-Agreement-with-Portugal-s-National-Health-Service.html\" target=\"_blank\" rel=\"noopener noreferrer\">Distributed by global newswire.com \u2192<\/a><\/p>\n<p><strong>About DoseMe<\/strong><\/p>\n<p><a href=\"https:\/\/doseme-rx.com\/\">DoseMe<\/a> is a Tabula Rasa HealthCare Company(NASDAQ: TRHC) and the first company in the world to develop precision dosing software &#8211; DoseMeRx &#8211; developed specifically for clinical practice.DoseMe&#8217;s clinical decision support solutions focus on empowering healthcare providers to optimize dosing of high-risk parenteral medications to streamline operations, reduce adverse drugs events, decrease costs and improve patient outcomes. For more information, visit <a href=\"https:\/\/doseme-rx.com\/\">doseme-rx.com<\/a><\/p>\n<p><strong>About Tabula Rasa HealthCare<\/strong><\/p>\n<p>Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.&nbsp;Medication risk management is TRHC\u2019s lead offering, and its cloud-based software applications, including EireneRx\u00ae and MedWise\u00ae, provide solutions for a range of payers, providers and other healthcare organizations.&nbsp; <a href=\"http:\/\/www.tabularasahealthcare.com\/\">www.tabularasahealthcare.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MOORESTOWN, N.J., (June 6, 2019) &#8211; Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), precision dosing software company DoseMe, today announced a three-year agreement with Portugal\u2019s National Health Service, Centro Hospitalar Lisboa Ocidental (CHLO) for DoseMe\u2019s proprietary dose optimization software &#8211; DoseMeRx. \u201cTherapeutic drug monitoring of medications that have a narrow therapeutic window is a challenging [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":7892,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8],"tags":[34],"article-type":[49],"class_list":["post-4119","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","tag-press-release"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service<\/title>\n<meta name=\"description\" content=\"DoseMe signs three-year agreement with Portugal\u2019s National Health Service for their proprietary dose optimization software - DoseMeRx.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service\" \/>\n<meta property=\"og:description\" content=\"DoseMe signs three-year agreement with Portugal\u2019s National Health Service for their proprietary dose optimization software - DoseMeRx.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service\" \/>\n<meta property=\"og:site_name\" content=\"DoseMeRx\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DoseMeApp\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-06T14:29:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-24T04:18:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1120\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicola Hunter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DoseMeApp\" \/>\n<meta name=\"twitter:site\" content=\"@DoseMeApp\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicola Hunter\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service","description":"DoseMe signs three-year agreement with Portugal\u2019s National Health Service for their proprietary dose optimization software - DoseMeRx.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service","og_locale":"it_IT","og_type":"article","og_title":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service","og_description":"DoseMe signs three-year agreement with Portugal\u2019s National Health Service for their proprietary dose optimization software - DoseMeRx.","og_url":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service","og_site_name":"DoseMeRx","article_publisher":"https:\/\/www.facebook.com\/DoseMeApp\/","article_published_time":"2019-06-06T14:29:28+00:00","article_modified_time":"2021-03-24T04:18:42+00:00","og_image":[{"width":1120,"height":630,"url":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png","type":"image\/png"}],"author":"Nicola Hunter","twitter_card":"summary_large_image","twitter_creator":"@DoseMeApp","twitter_site":"@DoseMeApp","twitter_misc":{"Scritto da":"Nicola Hunter","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#article","isPartOf":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service"},"author":{"name":"Nicola Hunter","@id":"https:\/\/doseme-rx.com\/it#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9"},"headline":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service","datePublished":"2019-06-06T14:29:28+00:00","dateModified":"2021-03-24T04:18:42+00:00","mainEntityOfPage":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service"},"wordCount":545,"commentCount":0,"image":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#primaryimage"},"thumbnailUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png","keywords":["Press Release"],"articleSection":["News &amp; Media Centre"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#respond"]}]},{"@type":"WebPage","@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service","url":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service","name":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service","isPartOf":{"@id":"https:\/\/doseme-rx.com\/it#website"},"primaryImageOfPage":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#primaryimage"},"image":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#primaryimage"},"thumbnailUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png","datePublished":"2019-06-06T14:29:28+00:00","dateModified":"2021-03-24T04:18:42+00:00","author":{"@id":"https:\/\/doseme-rx.com\/it#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9"},"description":"DoseMe signs three-year agreement with Portugal\u2019s National Health Service for their proprietary dose optimization software - DoseMeRx.","breadcrumb":{"@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#primaryimage","url":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png","contentUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2019\/06\/2.png","width":1120,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/doseme-rx.com\/it\/news-media\/articles\/portugals-national-health-service#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/doseme-rx.com\/it"},{"@type":"ListItem","position":2,"name":"DoseMe Signs 3-Year Agreement\u00a0with Portugal\u2019s National Health Service"}]},{"@type":"WebSite","@id":"https:\/\/doseme-rx.com\/it#website","url":"https:\/\/doseme-rx.com\/it","name":"DoseMeRx","description":"Choose us for our world-leading Bayesian dosing software. Stay with us for our best-in-class customer service.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/doseme-rx.com\/it?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/doseme-rx.com\/it#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9","name":"Nicola Hunter","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","caption":"Nicola Hunter"},"url":"https:\/\/doseme-rx.com\/it\/author\/nicola-hunter"}]}},"_links":{"self":[{"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/posts\/4119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/comments?post=4119"}],"version-history":[{"count":4,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/posts\/4119\/revisions"}],"predecessor-version":[{"id":7895,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/posts\/4119\/revisions\/7895"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/media\/7892"}],"wp:attachment":[{"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/media?parent=4119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/categories?post=4119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/tags?post=4119"},{"taxonomy":"article-type","embeddable":true,"href":"https:\/\/doseme-rx.com\/it\/wp-json\/wp\/v2\/article-type?post=4119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}